New meningitis vaccine launched in Africa
Partnerships key to developing low-cost health tool
A new meningitis vaccine costing 50 cents per dose was distributed for the first time on December 6 in Burkina Faso. The new vaccine marks the first time in history that a vaccine has been specifically designed for Africa. Developing this lifesaving vaccine highlights a highly successful partnership model and further emphasizes the role of key stakeholders—from the World Health Organization (WHO), pharmaceutical companies, product-development partnerships, the US Government, and manufacturers in the developing world—to improving access to much-needed health tools.
Read more 
World AIDS Day marked by breakthroughs in science
The run-up to this year's World AIDS Day on December 1 was studded with monumental achievements in HIV/AIDS prevention research. Over the last 16 months, we have seen several scientific breakthroughs that have the potential to change the course of the HIV/AIDS pandemic, including landmark discoveries in vaccines, microbicides, and using antiretroviral drugs for prevention.
Read more
Agency spotlight: OSTP
The White House's Office of Science and Technology Policy (OSTP) advises President Obama and others within the Executive Office of the President on the effects of science and technology on domestic and international affairs. OSTP is central to the Obama Administration's efforts to prioritize science and innovation as key pillars of the United States' international health and development policies.
Read more about OSTP and international development
Visit the OSTP website
Photos (top to bottom): PATH/Gabe Bienczycki, Willow Gerber, Satvir Malhotra |
 |
|
|
December 2010
UPCOMING EVENTS
January 10-12, 2011
5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
January 26, 2011
From the Bench to the Field and Back: A Global Approach to Dengue and Influenza
NEW AND NOTEWORTHY
State Department recognizes power of innovation and technology to transform lives in new development policy
US support key to recent breakthroughs in global health science, GHTC director writes
USAID releases report on health-related research and development activities
NIH board recommends new center to advance the development of health tools for neglected and rare diseases
GHTC director highlights role of US Government in recent HIV prevention study
Science and research are crucial to improving health worldwide, former assistant surgeon general writes in opinion piece
Investments in global health research “benefit lives” worldwide and can “be felt locally in the US,” according to blog post
MEMBER FOCUS
The WHO on December 8 announced that it has endorsed a new test for tuberculosis and drug resistance. The new test was co-developed by GHTC member the Foundation for Innovative New Diagnostics (FIND). Development of the new diagnostic was financed in part by the United States' lead agency for health research, the National Institutes of Health.
Read more |
|
Received this as a forward? Click here to sign up for future issues.
If you wish to unsubscribe, please click here to send us a message. We will remove your name from our mailing list as soon as possible.
The Global Health Technologies Coalition (GHTC) is a group of more than 30 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostic tests, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and improved regulatory systems. Learn more at www.ghtcoalition.org.
To see a list of GHTC members, click here.
We respect the privacy of our online relationships. our mailing lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law. |